Ebola virus causes severe hemorrhagic fever with a high fatality rate. Recent outbreaks occurred during 2013-2015 in West Africa. Human-to-human transmission is through contact with body fluids. Several strains of the virus have emerged including the Zaire, Sudan, and Bundi strains. The natural reservoir of this RNA virus is thought to be bats.
ViroStat has introduced new sets of monoclonal antibodies to two of the significant antigens of this virus; Nucleoprotein (NP) and VP40. These antibodies function in ELISA and western blot with both the Zaire and Sudan antigen sequences. As such, they offer powerful tools for the development of rapid immunoassays to aid in the detection of this virus.
Go to the ViroStat website, www.virostat-inc.com to download the data sheets of these new antibodies.
ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV, & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV, & EBV for use in anti-viral HTS assays.
PO Box 8522
Portland, ME 04104 USA
Like this article? Click here to subscribe to free newsletters from Lab Manager